Skip to content

Now, let me review all the GO functions and complexes in the model to fully understand its components:

Based on all the information gathered, I'll now provide a comprehensive review of the GO-CAM model gomodel:623d156d00000752.

Review of GO-CAM Model: 623d156d00000752

Model Overview

Title: Glycogen catabolic process 2 (Mouse)
Taxon: Mouse (NCBITaxon:10090)
Status: Production
Model URL: https://bioregistry.io/go.model:623d156d00000752

Model Assessment

This model represents the glycogen catabolic process in mice, detailing how different proteins contribute to breaking down glycogen in the cytosol. The model appears to be well-constructed with appropriate causal relationships between activities and is supported by relevant evidence from the literature.

Biological Process Representation

The model accurately captures the glycogen catabolic process (GO:0005980) in mouse cells, showing how multiple enzymatic activities coordinate to break down glycogen into glucose-6-phosphate, which can enter glycolysis. The activities include:

  1. Glycogen phosphorylase activity (GO:0008184) by PYGB (brain glycogen phosphorylase)
  2. 4-alpha-glucanotransferase activity (GO:0004134) and amylo-alpha-1,6-glucosidase activity (GO:0004135) by AGL (glycogen debranching enzyme)
  3. Phosphorylase kinase activity (GO:0004689) by PHKG1 (phosphorylase kinase gamma subunit)
  4. Phosphoglucomutase activities (GO:0004614) by PGM1 and PGM2

Molecular Structure and Specificity

The model correctly identifies the molecular functions of each protein involved:

  • PYGB (MGI:MGI:97828): The brain isoform of glycogen phosphorylase, responsible for cleaving α-1,4-glycosidic bonds in glycogen to release glucose-1-phosphate
  • AGL (MGI:MGI:1924809): Functions as both a transferase and glucosidase to handle the branched portions of glycogen
  • PHKG1 (MGI:MGI:97579): Activates glycogen phosphorylase through phosphorylation
  • PGM1/PGM2 (MGI:MGI:97565/97564): Convert glucose-1-phosphate to glucose-6-phosphate

Causal Connections

The causal relationships in the model are logically connected:

  1. PHKG1 positively regulates (RO:0002629) PYGB, which is consistent with its role in activating glycogen phosphorylase through phosphorylation
  2. PYGB provides input for (RO:0002413) AGL's transferase activity, PGM1, and PGM2, correctly indicating that products of the glycogen phosphorylase reaction serve as substrates for these enzymes
  3. AGL's transferase activity provides input for its glucosidase activity, correctly representing the sequence of reactions in debranching
  4. AGL's glucosidase activity provides input for PYGB activity, reflecting the cyclic nature of glycogen breakdown
  5. PGM1 and PGM2 produce alpha-D-glucose-6-phosphate as output, correctly showing the end product

Subcellular Localization

All activities are appropriately annotated as occurring in the cytosol (GO:0005829), which matches the known location of glycogen metabolism in cells.

Evidence and References

The model includes appropriate evidence codes and references: - Direct assay evidence (ECO:0000314) - Mutant phenotype evidence (ECO:0000315) - Sequence orthology evidence (ECO:0000266)

The primary references (PMID:32446205, PMID:24613482, PMID:4646763) provide strong support for the activities and relationships depicted in the model.

One of the main references (PMID:32446205) specifically describes glycogenolysis (glycogen breakdown) and its importance in brain function, which aligns well with the model's focus.

Compliance with GO-CAM Best Practices

The model follows GO-CAM best practices:

  1. Appropriate molecular functions are attributed to specific gene products
  2. Activities are connected with appropriate causal relationships
  3. Each molecular function is part of the appropriate biological process
  4. Subcellular locations are specified
  5. Evidence codes and references are provided for key assertions

Recommendations for Improvement

While the model is well-constructed, I have a few minor suggestions for improvement:

  1. Clarify cycle representation: The model shows AGL's glucosidase activity (GO:0004135) providing input to PYGB activity (GO:0008184). While this represents the cyclic nature of glycogen breakdown, it might be clearer to explicitly show that this represents a new cycle of glycogen degradation.

  2. Add additional regulatory inputs: The model could potentially benefit from including factors that regulate glycogen breakdown, such as hormonal signals (insulin, glucagon) or energy status sensors (AMPK).

  3. Include additional output connections: Consider showing how glucose-6-phosphate feeds into other metabolic pathways like glycolysis or the pentose phosphate pathway.

  4. Add more mechanistic details: If available, information about how PHKG1 is itself activated (e.g., by calcium signaling or hormones) could enhance the model's completeness.

Conclusion

Overall, this GO-CAM model (gomodel:623d156d00000752) is a well-constructed representation of the glycogen catabolic process in mice. It accurately depicts the molecular functions, relationships, and cellular locations involved in glycogen breakdown. The model is supported by appropriate evidence and references, and it follows GO-CAM best practices. With a few minor enhancements, it could provide an even more comprehensive view of glycogen metabolism regulation.

The model successfully connects the activities of glycogen phosphorylase, debranching enzyme, and phosphoglucomutase to represent how glycogen is broken down to produce glucose-6-phosphate in mouse cells, particularly in the brain.